An ex vivo study found that VENTX expression was significantly reduced in TAM of colon cancer patients, which could drive the intracellular signaling pathway TAM toward M1 phenotype, reversing immunosuppression in the tumor microenvironment and regulating TAM plasticity and immune status [10]. The gene discussed is VENTX; the disease is colonic neoplasm.